Connect with us


Urban Outfitters, KB Home, Repay Holdings & more



Check out the companies making headlines in after hours trading.

Urban Outfitters — Shares of the retailer slid more than 11% after Urban Outfitters said net sales for the two months ended Dec. 31 fell 8.4% year over year. The company also announced that CEO Trish Donnelly will depart at the end of the month.

KB Home — Shares of the homebuilder gained more than 2% after the company’s fourth quarter results topped expectations. KB Home earned $1.12 per share during the period on revenue of $1.19 billion. Analysts were expecting the company to earn 93 cents per share on $1.14 billion in revenue, according to estimates compiled by Refinitiv.

Repay Holdings — Shares of the financial technology company declined more than 5% after Repay announced a new share offering. The company said it was looking to raise $130 million through the new stock offering.

Ally Financial — Shares of the financial services company gained more than 3% after the company announced a $1.6 billion share repurchase program. The company will begin buying back stock during the current quarter.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


CDC changes Covid vaccine guidance to OK mixing Pfizer and Moderna shots




Bins of syringes for the Pfizer BioNtech and Moderna Inc. Covid-19 vaccines in Tucson, Arizona, U.S., on Friday, Jan. 15, 2021.

Cherry Orr | Bloomberg | Getty Images

The Centers for Disease Control and Prevention quietly changed its guidance on Covid-19 vaccine shots, saying it’s now OK to mix Pfizer and Moderna‘s shots in “exceptional situations” and that it’s also fine to wait up to six weeks to get the second shot of either company’s two-dose immunization.

While Pfizer and Moderna’s vaccines, which both use messenger RNA technology, were authorized to be given 21 and 28 days apart, respectively, the agency now says you can receive either shot so long as they are given least 28 days apart, according to new guidance posted on its website Thursday.

Although “every effort” should be made to ensure a patient receives the same vaccine, in rare situations “any available mRNA COVID-19 vaccine may be administered at a minimum interval of 28 days between doses” — if supplies are limited or the patient doesn’t know which vaccine they originally received, the CDC’s new guidance says.

The CDC says the two products are not interchangeable, and acknowledged that it hadn’t yet studied whether its new recommendations would change the safety or effectiveness of either vaccine.

The agency said health-care providers should give patients a vaccination record card that tells them when they received their first shot and which kind of shot it was to help ensure that patients know which shot they ought to receive the second time. The agency also recommends that providers enter the patient’s vaccination information into their medical records and the government’s immunization information system.

Both companies require two doses to achieve maximum protection from the coronavirus. While both shots should be administered according to the originally recommended guidelines, the CDC said the second dose of either companies’ vaccine could be delayed as long as six weeks if necessary.

The updated guidance comes as some cities and counties across the country are canceling vaccine appointments because they don’t have as many doses as they originally expected.

Wayne County, Michigan, for example, said last week it would prioritize making sure that people who got their first shot get their second shot on time. But the county said it had to cancel almost 1,400 appointments for people to get their first shot.

“The intent is not to suggest people do anything different, but provide clinicians with flexibility for exceptional circumstances,” Jason McDonald, a spokesman for CDC, said in an email to CNBC.

Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, was asked Friday about the interval at which the two shots should be administered.

“The data that we have is on a two-dose vaccine at the recommended schedule, 21 or 28 days,” she said at a virtual event hosted by the Harvard T.H. Chan School of Public Health and National Public Radio. “At this point we at CDC agree with what FDA has said and FDA has been very clear that we should be using the approved regimen.”

“It’s rooted solidly in the science and the available evidence, and to do something different than that would be not following the science and potentially not allowing us to really realize the full potential of these vaccines,” she added. “So for now, from the CDC perspective, we think that it has to be two doses on the recommended schedule.”

Source link

Continue Reading


Pfizer to supply up to 40 million Covid vaccine doses to Covax global program




A nurse prepares the Pfizer-BioNTech Covid-19 vaccine, at a vaccination center, in Sarcelles near Paris on January 10, 2021.

ALAIN JOCARD | AFP | Getty Images

Pfizer will supply up to 40 million doses of its coronavirus vaccine to a global alliance aiming to provide poor nations with coronavirus vaccines, the head of the World Health Organization said on Friday.

The deal will allow Covax — co-led by the WHO — to begin delivering vaccine doses to participating countries in February, WHO’s Director-General Tedros Adhanom Ghebreyesus said during a press briefing. Tedros added that, pending emergency authorization, the program expects 150 million doses of AstraZeneca‘s vaccine to become available for distribution in the first quarter of this year.

The Covax program aims to provide 2 billion doses of Covid-19 vaccines to participating countries, which includes low- to-middle income nations, by the end of this year. The Pfizer-BioNTech vaccine requires two shots spread weeks apart, indicating the agreement would cover just 20 million people.

Tedros said the agreement would also allow other countries with supplies of Pfizer’s vaccine to donate them to the program. The WHO chief has been critical of wealthy nations that have signed supply agreements with drugmakers for their initial doses of Covid-19 vaccines, stockpiling supplies away from poorer nations.

“This is not just significant for COVAX, it is a major step forward for equitable access to vaccines, and an essential part of the global effort to beat this pandemic. We will only be safe anywhere if we are safe everywhere,” Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, in a statement.

Pfizer CEO Albert Bourla said during the press briefing that the company will provide the doses of vaccine to Covax and the poorer nations at a cost. Pfizer was the first company to receive a global emergency use listing for its vaccine from the WHO, allowing other countries to expedite their regulatory approval processes to begin administering the vaccine.

Bourla said the company will help deliver the doses, which require ultra-cold storage and special handling, to low-income countries. UNICEF, which is helping deliver the doses, has previously warned some of the world’s poorest countries could face challenges storing and administering the shots once they arrive.

The program’s deal with Pfizer brings its supply agreements to just over 2 billion doses total, though it will continue negotiations for additional supply. The goal is to immunize health care and other frontline workers, as well as some high-risk individuals, beginning in the first quarter this year, according to Covax.

The deal comes on the heels of the United States’ decision to remain a member of the WHO under President Joe Biden. The new administration will also join the Covax program, a move that the Trump administration resisted last year.

“I just couldn’t avoid the temptation to say that I’m very glad that this press conference is happening the day that the United States is rejoining the WHO organization. I think it’s a symbolic, great day for us,” Pfizer chief Bourla said at the briefing.

Source link

Continue Reading


Hank Aaron, legendary baseball slugger, dies at age 86




Hank Aaron, the right fielder for the Atlanta Braves, shown in this close up photograph, was named to the National League All Star team for the 16th straight year.

Bettmann | Getty Images

National Baseball Hall of Famer Hank Aaron has died at age 86, a spokesperson confirmed Friday.

Aaron, considered one of the greatest players of all time, broke Babe Ruth’s home run record in 1974.

He now resides in the number two spot, behind Barry Bonds.

Hammerin’ Hank’s MLB career would span 23 years where he raked in 755 career home runs, an MVP trophy and a World Series win in 1957.

Born in 1934 in segregated Alabama, Aaron began his baseball career with the Indianapolis Clowns of the Negro American League in 1952 after leaving his hometown of Mobile with only two dollars in his hand.

“My mother told me that was all she had to give me and be very careful with it,” Aaron told NBC News in an interview last summer.

Aaron quickly transitioned into Major League Baseball, where he started playing for the Milwaukee Braves in 1954.

His debut in the MLB came seven years after Jackie Robinson first broke the sport’s color barrier, at a time when only 5% of players in the league were Black.

Even as Aaron gained renown as he chased Babe Ruth’s record, he continued to face racism.

“I couldn’t go out of the ballpark without an escort. I had to stay in another hotel, rather than stay in one with my teammates,” said Aaron in an NBC News interview, “it was the toughest moment of my life.”

Aaron would play with the Braves through their move to Atlanta until 1974, when he returned to Milwaukee to play for the Brewers.

This is breaking news. Please check back for updates.

Source link

Continue Reading

Breaking News